Understanding the neurodegenerative processes involved in MS, particularly the role of white matter (WM) and grey matter (GM), may help clinicians to diagnose the disease earlier and maximize ...

New clinical scales have been developed (such as the Multiple Sclerosis Functional Composite Scale 6), which provide a better estimation than the EDSS of overall clinical impairment.

The suite of self-monitored digital biomarkers was compared with traditional multiple sclerosis functional composite (MSFC) scores – as well as the expanded disability status scale (EDSS) – in ...

Multiple sclerosis (MS) is an inflammatory autoimmune disorder affecting the central nervous system (CNS) and the most common cause of neurological disability in young adults. Unidentified ...